Literature DB >> 3322014

The prevalence of autoantibodies in pregnant and nonpregnant women.

P E Patton1, C B Coulam, E Bergstralh.   

Abstract

The frequency of autoantibodies during pregnancy was studied. Sera from 136 women (84 pregnant and 52 nonpregnant) were tested for antibodies directed against nuclear antigens, smooth muscle antigens, gastric parietal cells, mitochondria, and striated muscle by indirect immunofluorescent microscopy. Rheumatoid factor was measured by a latex agglutination test, and thyroid microsomal and thyroglobulin antibodies were measured by a hemagglutination assay. Immunofluorescence assays were considered positive if antibodies were detected at a serum dilution of 1:20. All positive samples were retested at increasing dilutions until immunofluorescence or agglutination could not be detected. The control population consisted of 52 normal, healthy, ovulatory, and nonpregnant women. The study population consisted of 84 pregnant women, none of whom had a known autoimmune disorder. The mean ages of the two groups were 32 and 26 years, respectively. The frequency of autoantibody detection was not significantly different in comparing the study (46.2) and control groups (40.5). The results did not support the hypothesis that pregnancy has an effect on the induction or suppression of autoantibody production. Previous studies that suggested differences may have been influenced by the lack of a control group.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3322014     DOI: 10.1016/s0002-9378(87)80221-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  2 in total

1.  Occurence of autoantibodies in healthy Omani individuals.

Authors:  Ali A Al-Jabri; Elizabeth R Richens
Journal:  J Sci Res Med Sci       Date:  2001-04

2.  Harmless Pregnancy-Induced Warm Autoantibodies to Red Blood Cells.

Authors:  Gülüstan Sürücü; Beate Mayer; Anneliese Märzacker; Salih Yürek; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2015-09-10       Impact factor: 3.747

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.